Vor Biopharma Inc. SEC filings VOR
Vor Biopharma Inc. has 462 filings in SEC EDGAR's recent list, going back to Jul 10, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 30, 2026 | — |
| S-3ASR | Automatic shelf registration | Sep 4, 2026 | — |
| S-3 | Shelf registration | Apr 27, 2026 | — |
| S-8 | Employee stock plan registration | Mar 30, 2026 | — |
| 424B3 | Prospectus | Feb 5, 2026 | — |
| S-3 | Shelf registration | Jan 29, 2026 | — |
| 424B3 | Prospectus | Dec 1, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 10, 2025 | — |
| S-3/A | Filing | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Sep 24, 2025 | — |
| S-3 | Shelf registration | Sep 24, 2025 | — |
| 424B5 | Prospectus supplement | Aug 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| S-3 | Shelf registration | Mar 20, 2025 | — |
| 424B3 | Prospectus | Jan 29, 2025 | — |
| S-3 | Shelf registration | Jan 21, 2025 | — |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| S-8 | Employee stock plan registration | Aug 30, 2023 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| 424B5 | Prospectus supplement | Dec 23, 2022 | — |
| S-3 | Shelf registration | Dec 14, 2022 | — |
| 424B5 | Prospectus supplement | Dec 8, 2022 | — |
| S-3 | Shelf registration | Mar 14, 2022 | — |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| S-8 | Employee stock plan registration | Feb 9, 2021 | — |
| 424B4 | Prospectus | Feb 8, 2021 | — |
| S-1MEF | Filing | Feb 5, 2021 | — |
| FWP | Free writing prospectus | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 1, 2021 | — |
| S-1 | Registration statement | Jan 15, 2021 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VOR (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1817229
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.